Form4.ai tracks every SEC insider trade in real time. See every LGND insider filing with a free account — no card.
See every LGND insider filing — free account, no card.
Free accountLIGAND PHARMACEUTICALS INC (LGND) has 6 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $6.1M. Most recent filing: Nov. 3, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Nov 3, 2026 SEC filing | Aryeh Jason Director | Sold | $676,158 | — |
| Oct 6, 2026 SEC filing | Reardon Andrew CLO & Secretary | Sold | $1,416,962 | — |
| Sep 24, 2026 SEC filing | Zimmermann Martine Director | Tax withholding | $34,328 | — |
Create a free account to see all 6 LGND filings from the last 90 days. No card needed.
Create free accountWant LGND insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.